Dr. Celesteann Bremer

Claim this profile

Virginia Oncology Associates

Studies Multiple Myeloma
Studies Plasma Cell Neoplasms
1 reported clinical trial
1 drug studied

Affiliated Hospitals

Image of trial facility.
Virginia Oncology Associates

More about Celesteann Bremer

Clinical Trial Related1 year of experience running clinical trials · Led 1 trial as a Principal Investigator · 0 Active Clinical Trials
Treatments Celesteann Bremer has experience with
  • Modakafusp Alfa
Breakdown of trials Celesteann Bremer has run

Other Doctors you might be interested in

Frequently asked questions

Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Celesteann Bremer specialize in?
Celesteann Bremer focuses on Multiple Myeloma and Plasma Cell Neoplasms. In particular, much of their work with Multiple Myeloma has involved treating patients, or patients who are undergoing treatment.
Is Celesteann Bremer currently recruiting for clinical trials?
No, Celesteann Bremer is not currently recruiting for any clinical trials. This may change in the future, so check back later.
Are there any treatments that Celesteann Bremer has studied deeply?
Yes, Celesteann Bremer has studied treatments such as Modakafusp alfa.
What is the best way to schedule an appointment with Celesteann Bremer?
Apply for one of the trials that Celesteann Bremer is conducting.
What is the office address of Celesteann Bremer?
The office of Celesteann Bremer is located at: Virginia Oncology Associates, Virginia Beach, Virginia 23456 United States. This is the address for their practice at the Virginia Oncology Associates.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.